Ruder Finn has lost another senior practitioner with the client services director of the agency...third high profile departure from Ruder Finn this summer, following European innovation director Pat ...
Ruder Finn is to replace Ketchum on the account for Wyeth’s rheumatoid arthritis drug Enbrel....Ruder Finn grabbed the business after a competitive pitch that also included Red Health, Athena ...
Jaimie Brown has been made associate director at Ruder Finn's health and wellbeing division....Ruder Finn European innovation director Pat Pearson and ass ociate director Paul Gittins to the newly ...
Pharma firm Wyeth Pharmaceuticals has hired health specialist Ruder Finn to provide PR support in...Ruder Finn London has been handed the 12-month brief following a competitive pitch against three ...
Healthcare specialist Ruder Finn has been appointed to the 12-month account following a ...
A question of reputation The standing of pharmaceutical companies is at an all-time low, but there are ways trust can be restored, says Kathy Bloomgarden
In a climate of increasing Government red tape, regulatory support is emerging as a core skill for PA firms... says Hugh McKinney
Last year, Ruder Finn hosted a roundtable with the Foreign Press Association in London to discuss ...
Ruder Finn has appointed Mikhaila Berdy to a newly created associate director position....cardiovascular and oncology account with pharma firm Novartis. Meanwhile, Ruder Finn head of healthcare Claire ...
The Red Consultancy has raided Ruder Finn to fill the top two posts at its newly launched...The 20-strong division will be headed by Pat Pearson, who had been with Ruder Finn for nine years ...
to remove filters